Friday 25 June 2021 - livestream
A study day for multidisciplinary professionals that will cover supportive care and decision-making processes when treating head and neck cancer patients. We will discuss new and emerging therapies and the various risks to consider in ensuring maximum care for your patients.
Suitable for all nurses, Allied Health Professionals (especially speech and language therapists), junior doctors and registrars.
At Eisai, everything they do is dedicated to giving their first thought to patients and their families through their human health care (hhc) philosophy. They are the European hub of Tokyo-based Eisai Co. Ltd., forming part of a multinational team working across a global network of R&D facilities, manufacturing sites and marketing subsidiaries.
Eisai’s collective passion and dedication to patient care is the driving force behind their efforts to discover and develop innovative medicines in a variety of therapeutic areas in which a high unmet medical need remains, including oncology and neurology.
Their mission is clear; they strive to make a significant long-lasting contribution to society in an ethical, compliant and sustainable way by embodying their hhc philosophy in everything they do.
For more information about Eisai in the European, Middle Eastern and African (EMEA region), please visit the Eisai website.
If you are interested in sponsoring this event, please contact us via email.
Sign up to our education events mailing list to be kept up to date with this and future events
© 2023 The Christie NHS Foundation Trust
The Christie Charity